The hospital-acquired infection control market size has grown strongly in recent years. It will grow from $35.75 billion in 2025 to $37.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising incidence of hospital-acquired infections, increased use of invasive medical procedures, growing awareness of patient safety standards, expansion of intensive care units, stricter hospital hygiene regulations.
The hospital-acquired infection control market size is expected to see strong growth in the next few years. It will grow to $46.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing regulatory enforcement on infection control, rising adoption of automated sterilization technologies, growing demand for rapid microbial testing, expansion of surveillance and reporting systems, increasing investments in hospital infection prevention infrastructure. Major trends in the forecast period include increasing focus on preventing cross-contamination in hospitals, rising adoption of advanced sterilization and disinfection protocols, growing emphasis on continuous infection surveillance, expansion of automated and high-level disinfection solutions, increasing demand for comprehensive infection prevention programs.
Increasing healthcare expenditures are expected to drive the growth of the hospital-acquired infection control market. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specified period, whether at the individual, community, national, or global level. With rising healthcare spending, hospitals and healthcare facilities are likely to allocate additional resources toward advanced infection prevention technologies, including innovative solutions such as advanced disinfection systems, smart monitoring devices, and other tools that strengthen overall infection control measures. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure rose by 5.6% in nominal terms between 2022 and 2023, compared with 0.9% growth in 2022. Consequently, increasing healthcare expenditure is expected to propel the hospital-acquired infection control market in the coming years.
Key players in the hospital-acquired infection control market are concentrating on developing technological solutions, such as AI systems for early sepsis detection, to improve patient outcomes by enabling rapid diagnosis and treatment. AI systems for sepsis detection utilize artificial intelligence and machine learning algorithms to identify early signs of sepsis in patients. For instance, in April 2024, US-based medical clinic Prenosis Inc. received FDA marketing authorization for the Sepsis ImmunoScore, the first AI-driven system designed to predict sepsis, a life-threatening condition that can cause severe complications. This innovative tool facilitates early detection through real-time data analysis, allowing healthcare professionals to intervene more quickly and effectively. The integration of AI is intended to support medical decision-making rather than replace staff, ultimately improving patient outcomes and reducing healthcare costs.
In August 2024, MicroCare LLC, a US-based manufacturer of cleaning and disinfecting products for medical use, acquired ICT Infection Control Technologies for an undisclosed amount. This acquisition enables MicroCare to expand its healthcare portfolio by integrating ICT’s specialized infection control solutions with MicroCare’s existing range of cleaning and lubrication products. This strategic move strengthens MicroCare’s position in the rapidly growing medical infection prevention market, enhancing the safety and effectiveness of cleaning solutions for healthcare facilities. ICT Infection Control Technologies is a US-based company specializing in manufacturing infection control chemistries primarily for dental and medical applications.
Major companies operating in the hospital-acquired infection control market are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
North America was the largest region in the hospital-acquired infection control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hospital-acquired infection control market by increasing the cost of imported sterilization equipment, disinfectors, microbial testing instruments, and specialized consumables. These effects are most pronounced in equipment- and consumable-intensive segments and in regions such as North America and Europe that depend on global medical device and chemical supply chains. Higher input costs may affect procurement budgets for hospitals; however, tariffs are also encouraging local manufacturing, regional sourcing of disinfectants and consumables, and adoption of cost-efficient infection control solutions, supporting long-term supply stability.
The hospital-acquired infection control market research report is one of a series of new reports that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hospital-acquired infections are infections that occur during hospital care and are not present prior to admission. The prevention and management of these infections through various cleaning, sterilization, and disinfection techniques is referred to as hospital-acquired infection control. These infections can result from cross-contamination via equipment surfaces, patient skin, or healthcare staff. Hospital-acquired infection control aims to reduce or eliminate the transmission of such illnesses.
The primary product categories in hospital-acquired infection control include sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers are devices designed to make equipment completely clean and free of bacteria, eliminating germs on surfaces or in fluids to prevent disease transmission. Key technologies encompass phenotypic and genotypic methods and target a range of diseases, including hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications include disease testing and drug-resistance testing. End users include hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and other healthcare facilities.
The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hospital-acquired infection control market size is expected to see strong growth in the next few years. It will grow to $46.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing regulatory enforcement on infection control, rising adoption of automated sterilization technologies, growing demand for rapid microbial testing, expansion of surveillance and reporting systems, increasing investments in hospital infection prevention infrastructure. Major trends in the forecast period include increasing focus on preventing cross-contamination in hospitals, rising adoption of advanced sterilization and disinfection protocols, growing emphasis on continuous infection surveillance, expansion of automated and high-level disinfection solutions, increasing demand for comprehensive infection prevention programs.
Increasing healthcare expenditures are expected to drive the growth of the hospital-acquired infection control market. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specified period, whether at the individual, community, national, or global level. With rising healthcare spending, hospitals and healthcare facilities are likely to allocate additional resources toward advanced infection prevention technologies, including innovative solutions such as advanced disinfection systems, smart monitoring devices, and other tools that strengthen overall infection control measures. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure rose by 5.6% in nominal terms between 2022 and 2023, compared with 0.9% growth in 2022. Consequently, increasing healthcare expenditure is expected to propel the hospital-acquired infection control market in the coming years.
Key players in the hospital-acquired infection control market are concentrating on developing technological solutions, such as AI systems for early sepsis detection, to improve patient outcomes by enabling rapid diagnosis and treatment. AI systems for sepsis detection utilize artificial intelligence and machine learning algorithms to identify early signs of sepsis in patients. For instance, in April 2024, US-based medical clinic Prenosis Inc. received FDA marketing authorization for the Sepsis ImmunoScore, the first AI-driven system designed to predict sepsis, a life-threatening condition that can cause severe complications. This innovative tool facilitates early detection through real-time data analysis, allowing healthcare professionals to intervene more quickly and effectively. The integration of AI is intended to support medical decision-making rather than replace staff, ultimately improving patient outcomes and reducing healthcare costs.
In August 2024, MicroCare LLC, a US-based manufacturer of cleaning and disinfecting products for medical use, acquired ICT Infection Control Technologies for an undisclosed amount. This acquisition enables MicroCare to expand its healthcare portfolio by integrating ICT’s specialized infection control solutions with MicroCare’s existing range of cleaning and lubrication products. This strategic move strengthens MicroCare’s position in the rapidly growing medical infection prevention market, enhancing the safety and effectiveness of cleaning solutions for healthcare facilities. ICT Infection Control Technologies is a US-based company specializing in manufacturing infection control chemistries primarily for dental and medical applications.
Major companies operating in the hospital-acquired infection control market are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
North America was the largest region in the hospital-acquired infection control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hospital-acquired infection control market by increasing the cost of imported sterilization equipment, disinfectors, microbial testing instruments, and specialized consumables. These effects are most pronounced in equipment- and consumable-intensive segments and in regions such as North America and Europe that depend on global medical device and chemical supply chains. Higher input costs may affect procurement budgets for hospitals; however, tariffs are also encouraging local manufacturing, regional sourcing of disinfectants and consumables, and adoption of cost-efficient infection control solutions, supporting long-term supply stability.
The hospital-acquired infection control market research report is one of a series of new reports that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hospital-acquired infections are infections that occur during hospital care and are not present prior to admission. The prevention and management of these infections through various cleaning, sterilization, and disinfection techniques is referred to as hospital-acquired infection control. These infections can result from cross-contamination via equipment surfaces, patient skin, or healthcare staff. Hospital-acquired infection control aims to reduce or eliminate the transmission of such illnesses.
The primary product categories in hospital-acquired infection control include sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers are devices designed to make equipment completely clean and free of bacteria, eliminating germs on surfaces or in fluids to prevent disease transmission. Key technologies encompass phenotypic and genotypic methods and target a range of diseases, including hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications include disease testing and drug-resistance testing. End users include hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and other healthcare facilities.
The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hospital-Acquired Infection Control Market Characteristics
3. Hospital-Acquired Infection Control Market Supply Chain Analysis
4. Global Hospital-Acquired Infection Control Market Trends and Strategies
5. Hospital-Acquired Infection Control Market Analysis of End Use Industries
7. Global Hospital-Acquired Infection Control Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hospital-Acquired Infection Control Total Addressable Market (TAM) Analysis for the Market
9. Hospital-Acquired Infection Control Market Segmentation
10. Hospital-Acquired Infection Control Market Regional and Country Analysis
11. Asia-Pacific Hospital-Acquired Infection Control Market
12. China Hospital-Acquired Infection Control Market
13. India Hospital-Acquired Infection Control Market
14. Japan Hospital-Acquired Infection Control Market
15. Australia Hospital-Acquired Infection Control Market
16. Indonesia Hospital-Acquired Infection Control Market
17. South Korea Hospital-Acquired Infection Control Market
18. Taiwan Hospital-Acquired Infection Control Market
19. South East Asia Hospital-Acquired Infection Control Market
20. Western Europe Hospital-Acquired Infection Control Market
21. UK Hospital-Acquired Infection Control Market
22. Germany Hospital-Acquired Infection Control Market
23. France Hospital-Acquired Infection Control Market
24. Italy Hospital-Acquired Infection Control Market
25. Spain Hospital-Acquired Infection Control Market
26. Eastern Europe Hospital-Acquired Infection Control Market
27. Russia Hospital-Acquired Infection Control Market
28. North America Hospital-Acquired Infection Control Market
29. USA Hospital-Acquired Infection Control Market
30. Canada Hospital-Acquired Infection Control Market
31. South America Hospital-Acquired Infection Control Market
32. Brazil Hospital-Acquired Infection Control Market
33. Middle East Hospital-Acquired Infection Control Market
34. Africa Hospital-Acquired Infection Control Market
36. Hospital-Acquired Infection Control Market Competitive Landscape and Company Profiles
37. Hospital-Acquired Infection Control Market Other Major and Innovative Companies
40. Hospital-Acquired Infection Control Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Hospital-Acquired Infection Control Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hospital-acquired infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hospital-acquired infection control? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hospital-acquired infection control market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products2) By Technology: Phenotypic Methods; Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
4) By Application: Disease Testing; Drug-Resistance Testing
5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
8) By Other Products: Cleaning Equipment; Air Purification Systems
Companies Mentioned: Johnson and Johnson; P&G Professional; Honeywell International Inc.; MMM Group; 3M Company; Becton Dickinson and Company; Reckitt Benckiser Group plc.; Ecolab Inc; Olympus Corporation; Miele Group; Biomerieux SA; Getinge AB; Halyard Health Inc.; Ansell Limited; Sotera Health LLC; Contec Inc.; Cantel Medical Corp.; Belimed AG; Nanosonics Limited; Advanced Sterilization Products Services Inc; Steelco S.P.A; Schülke & Mayr GmbH; Metrex Research LLC; Tristel Solutions Ltd.; Whiteley Corporation; PDI Inc.; Steris Healthcare PVT Ltd; Matachana Group; Pal International Ltd.; Xttrium Laboratories Inc.; Zep Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hospital-Acquired Infection Control market report include:- Johnson and Johnson
- P&G Professional
- Honeywell International Inc.
- MMM Group
- 3M Company
- Becton Dickinson and Company
- Reckitt Benckiser Group plc.
- Ecolab Inc
- Olympus Corporation
- Miele Group
- Biomerieux SA
- Getinge AB
- Halyard Health Inc.
- Ansell Limited
- Sotera Health LLC
- Contec Inc.
- Cantel Medical Corp.
- Belimed AG
- Nanosonics Limited
- Advanced Sterilization Products Services Inc
- Steelco S.P.A
- Schülke & Mayr GmbH
- Metrex Research LLC
- Tristel Solutions Ltd.
- Whiteley Corporation
- PDI Inc.
- Steris Healthcare PVT Ltd
- Matachana Group
- Pal International Ltd.
- Xttrium Laboratories Inc.
- Zep Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 37.7 Billion |
| Forecasted Market Value ( USD | $ 46.32 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
